MARKET INSIGHT: Branded & Generic Specialty Pharma Industry 2018
This Market Insight report covers Branded & Generic Specialty Pharma in 2018. So far, the specialty pharmaceutical industry has seen many major developments. After years of pain on both the branded side (down 53% from July 2015 highs) and in the generics space (down 46% from peak valuations in April 2015), there are finally signs of stability –and growth –for both.
Read our 2018 Market Insight on the CDMO Industry here.
Click here to view this report in its entirety.